Coronavirus and Arthritis: What You Need to Know
Learn what the current science says about COVID-19 and how it may affect people with arthritis.
Get answers to top questions about the coronavirus and arthritis so you can best protect yourself and your family. As we continue to monitor the pandemic, news about virus may change, so check back regularly.
Infection Risk and Prevention
- Transmission and contagiousness
- Complications and mortality risk
- Protective Measures
Symptoms and Exposure
- Common symptoms and disease course
- Immunity and re-infection
- What to do in case of virus exposure
Medications and Treatments
- Arthritis medications and infection risk
- Experimental and approved treatments for COVID-19
- Medication shortages
- Vaccine news and developments
- Vaccine effectivess and response
- Recommendations about boosters and more
Juvenile Arthritis and COVID-19
- Infection risk and possible complications for children with JA
- Symptoms in children
- Protective measures for entire family
Recovery and Outcomes
- Likelihood of hospitalization and complications with arthritis
- Hospital recovery outcomes for people with autoimmune diseases
- Mortality risk for people with autoimmune diseases
Coronavirus and COVID-19 Experts
Our gratitude to the following contributors and reviewers:
Jeffrey Curtis, MD, MPH, professor of medicine, rheumatology and immunology and senior scientist, University of Alabama, Birmingham
Liana Fraenkel, MD, a rheumatologist and professor of medicine at Yale Medical School in New Haven, Connecticut.
Michael George, MD, rheumatologist and assistant professor of medicine and epidemiology at the University of Pennsylvania, in Philadelphia
Yukiko Kimura, MD, chief of pediatric rheumatology, Joseph M. Sanzari Children’s Hospital and professor of pediatrics at Hackensack Meridian School of Medicine at Seton Hall, South Orange, New Jersey
Silvia Lapidus, MD, pediatric rheumatology, Hackensack Meridian Health in New Jersey
Andrew Laster, MD, rheumatologist, Arthritis & Osteoporosis Consultants of the Carolinas, in Charlotte
Erica Lawson, MD, pediatric rheumatologist and associate professor University of California, San Francisco
Peter Nigrovic, MD, associate professor of medicine, Harvard Medical School, director, Center for Adults with Pediatric Rheumatic Illness (CAPRI), Brigham & Women’s Hospital, Boston
Daniel Solomon, MD, MPH, rheumatologist, Brigham and Women's Hospital in Boston, professor of medicine, Harvard Medical School
Richard K. Vehe, MD, director of the Division of Pediatric Rheumatology at University of Minnesota Medical School in Minneapolis
Jennifer Weiss, MD, pediatric rheumatologist, Hackensack Meridian Health in New Jersey
Kevin Winthrop, MD, a specialist in infectious disease epidemiology at OHSU School of Medicine in Portland, Oregon
Learn about the vaccines that help the body fight against the SARS-CoV-2 virus.
Learn what happens before, during and after a COVID-19 vaccination.
Treatments for COVID-19 should be prescribed by your doctor. Learn about common treatments if you get sick.
Learn about distribution efforts in your state.
The COVID-19 Global Rheumatology Alliance is a registry for health care providers to enter data about rheumatology patients infected by the coronavirus. Talk to your doctor about supporting this effort to help clinicians evaluate risks, assess and treat patients.
Find a list of resources to help answer your questions about medication costs, supply and access during the pandemic.
Sign up today for email updates on coronavirus and arthritis.